Lymphographic-Like Technique for the Treatment of Microcystic Lymphatic Malformation Components of <3 mm

References

1. 1.↵
   2. Burrows PE,
   3. Mitri RK,
   4. Alomari A, et al

   . Percutaneous sclerotherapy of lymphatic malformations with doxycycline. Lymphat Res Biol 2008;6:209–16 pmid:19093794

   CrossRefPubMed
2. 2.↵
   2. Chaudry G,
   3. Burrows PE,
   4. Padua HM, et al

   . Sclerotherapy of abdominal lymphatic malformations with doxycycline. J Vasc Interv Radiol 2011;22:1431–35 doi:10.1016/j.jvir.2011.06.021 pmid:21821431

   CrossRefPubMedWeb of Science
3. 3.↵
   2. Bai Y,
   3. Jia J,
   4. Huang XX, et al

   . Sclerotherapy of microcystic lymphatic malformations in oral and facial regions. J Oral Maxillofac Surg 2009;67:251–56 doi:10.1016/j.joms.2008.06.046 pmid:19138596

   CrossRefPubMed
4. 4.↵
   2. Chaudry G,
   3. Guevara CJ,
   4. Rialon KL, et al

   . Safety and efficacy of bleomycin sclerotherapy for microcystic lymphatic malformation. Cardiovasc Intervent Radiol 2014;37:1476–81 doi:10.1007/s00270-014-0932-z pmid:24938907

   CrossRefPubMed
5. 5.↵
   2. Hogeling M,
   3. Adams S,
   4. Law J, et al

   . Lymphatic malformations: clinical course and management in 64 cases. Australas J Dermatol 2011;52:186–90 doi:10.1111/j.1440-0960.2011.00777.x pmid:21834813

   CrossRefPubMed
6. 6.↵
   2. Whimster I

   . The pathology of lymphangioma circumscriptum. Br J Dermatol 1976;94:473–86 doi:10.1111/j.1365-2133.1976.tb05134.x pmid:1268059

   CrossRefPubMedWeb of Science
7. 7.↵
   2. Giguère CM,
   3. Bauman NM,
   4. Sato Y, et al

   . Treatment of lymphangiomas with OK-432 (Picibanil) sclerotherapy: a prospective multi-institutional trial. Arch Otolaryngol Head Neck Surg 2002;128:1137–44 doi:10.1001/archotol.128.10.1137 pmid:12365884

   CrossRefPubMedWeb of Science
8. 8.↵
   2. Lee J,
   3. Lee SJ,
   4. Chung HY, et al

   . Infusion sclerotherapy of microcystic lymphatic malformation: clinico-radiological mid-term results. J Korean Soc Radiol 2016;74:26–36 doi:10.3348/jksr.2016.74.1.26

   CrossRef
9. 9.↵
   2. Mathur NN,
   3. Rana I,
   4. Bothra R, et al

   . Bleomycin sclerotherapy in congenital lymphatic and vascular malformations of head and neck. Int J Pediatr Otorhinolaryngol 2005;69:75–80 doi:10.1016/j.ijporl.2004.08.008 pmid:15627451

   CrossRefPubMedWeb of Science
10. 10.↵
    2. Nehra D,
    3. Jacobson L,
    4. Barnes P, et al

    . Doxycycline sclerotherapy as primary treatment of head and neck lymphatic malformations in children. J Pediatr Surg 2008;43:451–60 doi:10.1016/j.jpedsurg.2007.10.009 pmid:18358281

    CrossRefPubMed
11. 11.↵
    2. Herbreteau D,
    3. Riche MC,
    4. Enjolras O, et al

    . Percutaneous embolization with Ethibloc of lymphatic cystic malformations with a review of the experience in 70 patients. Int Angiol 1993;12:34–39 pmid:8376909

    PubMedWeb of Science
12. 12.↵
    2. Shergill A,
    3. John P,
    4. Amaral JG

    . Doxycycline sclerotherapy in children with lymphatic malformations: outcomes, complications and clinical efficacy. Pediatr Radiol 2012;42:1080–88 doi:10.1007/s00247-012-2406-2 pmid:22648390

    CrossRefPubMed
13. 13.↵
    2. Yura J,
    3. Hashimoto T,
    4. Tsuruga N, et al

    . Bleomycin treatment for cystic hygroma in children. Nihon Geka Hokan 1977;46:607–14 pmid:73364

    PubMed
14. 14.↵
    2. Levy RL,
    3. Chiarillo S

    . Hyperpyrexia, allergic-type response and death occurring with low-dose bleomycin administration. Oncology 1980;37:316–17 pmid:6160440

    CrossRefPubMed
15. 15.↵
    2. Sung MW,
    3. Chang SO,
    4. Choi JH, et al

    . Bleomycin sclerotherapy in patients with congenital lymphatic malformation in the head and neck. Am J Otolaryngol 1995;16:236–41 doi:10.1016/0196-0709(95)90149-3 pmid:7573743

    CrossRefPubMed
16. 16.↵
    2. Sainsbury DC,
    3. Kessell G,
    4. Fall AJ, et al

    . Intralesional bleomycin injection treatment for vascular birthmarks: a 5-year experience at a single United Kingdom unit. Plast Reconstr Surg 2011;127:2031–44 doi:10.1097/PRS.0b013e31820e923c pmid:21532430

    CrossRefPubMed
17. 17.↵
    2. Spence J,
    3. Krings T,
    4. terBrugge KG, et al

    . Percutaneous sclerotherapy for facial venous malformations: subjective clinical and objective MR imaging follow-up results. AJNR Am J Neuroradiol 2010;31:955–60 doi:10.3174/ajnr.A1940 pmid:20044505

    Abstract/FREE Full Text